Dengue Severity Classification (WHO 2009)
Classifies dengue fever severity using WHO 2009 criteria. Guides fluid management, monitoring, and hospital admission decisions.
Score interpretation
No warning sign or severe feature (WHO 2009).
→ Outpatient management; oral fluids; paracetamol; avoid NSAIDs; return precautions
At least one warning sign and no severe feature.
→ Hospital admission; IV fluid resuscitation; close monitoring of haematocrit and platelets
Severe plasma leakage, severe bleeding or severe organ involvement.
→ ICU admission; aggressive fluid resuscitation; blood products if severe bleeding; organ support
Interpretation bands for the Dengue Severity. Apply clinical judgement and local guidance.
References
Related
Curated clinical cross-links plus same-class fallbacks.
- Vancomycin (Paediatric) · Glycopeptide Antibiotic — MRSA / Severe Gram-Positive Infections in Children
- Meropenem (Paediatric) · Carbapenem — Severe / MDR Gram-Negative Infections / Febrile Neutropenia
- Tezepelumab (CRSwNP / Severe Asthma) · Anti-TSLP (Thymic Stromal Lymphopoietin) Monoclonal Antibody
- Flucloxacillin · Penicillinase-Resistant Penicillin — Staphylococcal Infections
- Ceftazidime · Third-Generation Cephalosporin — Pseudomonas / Gram-Negative Infections
- Teicoplanin · Glycopeptide Antibiotic — MRSA / Gram-Positive Infections
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.